Search Orphan Drug Designations and Approvals
-
Generic Name: | N-Hydroxy-4-(3-methyl-2-(S)phenyl-butyrylamino)benzamide |
---|---|
Date Designated: | 01/13/2012 |
Orphan Designation: | Treatment of Schwannoma of the central nervous system |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Recursion Pharmaceuticals Inc. 41 S. Rio Grande Street Salt Lake City, Utah 84101 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-